NCT00454116View on ClinicalTrials.gov

A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

November 30, 2009

Conditions
Colorectal Cancer
Interventions
DRUG

Vandetanib

once daily oral tablet two doses

DRUG

FOLFIRI

Intravenous infusion

Trial Locations (21)

Unknown

Research Site, Ann Arbor

Research Site, New York

Research Site, Nashville

Research Site, Salt Lake City

Research Site, Buenos Aires

Research Site, Ramos Mejía

Research Site, Rosario

Research Site, Santa Fe

Research Site, Vicente López

Research Site, Bergen

Research Site, Oslo

Research Site, Stavanger

Research Site, Seoul

Research Site, A Coruña

Research Site, Barcelona

Research Site, Jaén

Research Site, Lleida

Research site, Belfast

Research Site, Aberdeen

Research Site, Leicester

Research Site, Manchester

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00454116 - A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients | Biotech Hunter | Biotech Hunter